Company News: Pfizer (PFE) quarterly results beat analysts’ forecasts

Market news

31 July 2018

Company News: Pfizer (PFE) quarterly results beat analysts’ forecasts

Pfizer (PFE) reported Q2 FY 2018 earnings of $0.81 per share (versus $0.67 in Q2 FY 2017), beating analysts' consensus estimate of $0.74.

The company's quarterly revenues amounted to $13.466 bln (+4.4% y/y), beating analysts' consensus estimate of $13.298 bln.

The company also issued guidance for FY 2018, projecting EPS of $2.95-3.05 (compared to its prior guidance of $2.90-3.00 and analysts' consensus estimate of $2.95) and revenues of $53-55 bln (compared to its prior guidance of $53.5-55.5 bln and analysts' consensus estimate of $54.25 bln).

PFE fell to $38.50 (-0.23%) in pre-market trading.

Company News: Procter & Gamble (PG) quarterly earnings beat analysts’ estimate

Between March and May, Russia’s holdings of US Treasury bonds plummeted by $81 billion, representing 84% of its total US debt holdings - CNN

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.